HER-2 amplification and toptisomerase IIalpha gene aberrations as predictive markers in node-positive breast cancer patients randomly treated either with an anthracycline-based therapy or with cyclophosphamide, methotrexate, and 5-fluorouracil

Leo A Di, J Isola, MJ Piccart, D Gancberg, D Larsimont, M Tanner, T Järvinen, G Rouas, S Dolci, J-Y Leroy, M Paesmans

Research output: Contribution to journalArticleScientificpeer-review

241 Citations (Scopus)
Original languageEnglish
Pages (from-to)1107-1116
JournalClinical Cancer Research
Publication statusPublished - 2002
Publication typeA1 Journal article-refereed

Cite this